ArticleFrontiers in chemistry2024

Exploration of commercial cyclen-based chelators for mercury-197 m/g incorporation into theranostic radiopharmaceuticals.

Parmissa Randhawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.